2021
Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies
Shallis RM, Bewersdorf JP, Swoboda DM, Wei W, Gowda L, Prebet T, Halene S, Pillai MM, Parker T, Neparidze N, Podoltsev NA, Seropian S, Sallman DA, Gore SD, Zeidan AM. Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies. Clinical Lymphoma Myeloma & Leukemia 2021, 21: e483-e487. PMID: 33551344, DOI: 10.1016/j.clml.2021.01.003.Peer-Reviewed Original Research
2014
Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.
Neparidze N, Lacy J. Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments. Clinical Advances In Hematology And Oncology 2014, 12: 358-71. PMID: 25003566.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusClinical featuresEBV-specific T-cell therapyInhibition of EBVTreatment of EBVT-cell lymphomaT-cell therapyNew treatment strategiesEBV vaccineImmune dysregulationHodgkin's lymphomaNasopharyngeal cancerTreatment strategiesGastric cancerTherapeutic approachesBurkitt's lymphomaEBV oncogenesisAntiviral drugsLymphoid neoplasmsViral infectionLymphomaImmunogenic propertiesLytic viral infectionPathobiologyMalignancy
2011
Understanding the Role of Natural Killer T Cells in Hematologic Malignancies: Progress and Challenges
Neparidze N, Dhodapkar M. Understanding the Role of Natural Killer T Cells in Hematologic Malignancies: Progress and Challenges. Cancer Drug Discovery And Development 2011, 153-167. DOI: 10.1007/978-1-4614-0613-6_9.Peer-Reviewed Original ResearchNatural killer T cellsKiller T cellsNKT cellsHematologic malignanciesT cellsImportant effector cellsPreliminary clinical studyAnti-tumor effectsNKT functionDendritic cellsTumor immunityEffector cellsHematologic tumorsClinical studiesMalignancyQualitative defectsPatientsCD1dType IAttractive targetCellsVivoClinicNKTTumors